Skip to main content

Polymeric Nanocarriers for Non-Viral Gene Delivery

Buy Article:

$107.14 + tax (Refund Policy)

Gene therapy holds great promise for the treatment of acquired and inherited diseases. Non-viral gene delivery systems are gaining recognition as alternatives to viral gene vectors due to their safety and low immunogenicity. The effective delivery of nucleic acids requires overcoming many biological barriers that would otherwise hinder transfection efficiency. Developing safe and efficient vectors that can overcome these obstacles is at the heart of current gene delivery research. Polymeric nanocarriers, such as polyethylenimine (PEI), poly(L-lysine) (PLL), poly[2-(dimethylamino) ethyl methacrylate] (PDMAEMA), polyamidoamine (PAMAM), chitosan and poly(amino-co-ester)s (PAEs), play an important role in gene delivery. In this review, we first describe the current understanding of the biological barriers to non-viral gene delivery and recent progress in addressing these barriers. Several of the most widely used non-viral polymeric nanocarriers are discussed, and detailed strategies that have accumulated from nearly two decades of research aimed at overcoming biological barriers and improving gene transfer are highlighted.

Keywords: CHITOSAN; GENE DELIVERY; NON-VIRAL; POLYMERIC NANOCARRIERS

Document Type: Review Article

Publication date: 01 May 2015

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content